These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 15932348

  • 1. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis.
    Bosma R, Wynia K, Havlíková E, De Keyser J, Middel B.
    Acta Neurol Scand; 2005 Jul; 112(1):1-5. PubMed ID: 15932348
    [Abstract] [Full Text] [Related]

  • 2. Short-term effects of desmopressin on water and electrolyte excretion in adults with nocturnal polyuria.
    Chang YL, Lin AT, Chen KK.
    J Urol; 2007 Jun; 177(6):2227-9; discussion 2230. PubMed ID: 17509326
    [Abstract] [Full Text] [Related]

  • 3. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
    Kamperis K, Rittig S, Radvanska E, Jørgensen KA, Djurhuus JC.
    J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
    [Abstract] [Full Text] [Related]

  • 4. Antidiuresis: a new concept in managing female daytime urinary incontinence.
    Robinson D, Cardozo L, Akeson M, Hvistendahl G, Riis A, Norgaard JP.
    BJU Int; 2004 May; 93(7):996-1000. PubMed ID: 15142150
    [Abstract] [Full Text] [Related]

  • 5. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial.
    Valiquette G, Herbert J, Maede-D'Alisera P.
    Arch Neurol; 1996 Dec; 53(12):1270-5. PubMed ID: 8970454
    [Abstract] [Full Text] [Related]

  • 6. An open, in-patient incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia.
    Eckford SD, Carter PG, Jackson SR, Penney MD, Abrams P.
    Br J Urol; 1995 Oct; 76(4):459-63. PubMed ID: 7551881
    [Abstract] [Full Text] [Related]

  • 7. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
    De Guchtenaere A, Vande Walle C, Van Sintjan P, Donckerwolcke R, Raes A, Dehoorne J, Van Laecke E, Hoebeke P, Vande Walle J.
    J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL, Walle CV, Vansintjan P, Raes AM, De Guchtenaere AR, Van Laecke E, Hoebeke P, Vande Walle JG.
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [Abstract] [Full Text] [Related]

  • 9. Desmopressin for the treatment of nocturnal bedwetting in patients with neural tube closure defects.
    Del Gado R, Aceto G, Del Gaizo D, Del Gado G, Polidori G, Chiozza ML.
    J Urol; 2004 Apr; 171(4):1656-8. PubMed ID: 15017260
    [Abstract] [Full Text] [Related]

  • 10. Desmopressin for nocturia and enuresis associated with multiple sclerosis.
    Ferreira E, Letwin SR.
    Ann Pharmacother; 1998 Jan; 32(1):114-6. PubMed ID: 9475830
    [No Abstract] [Full Text] [Related]

  • 11. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P, Rezapour M, Cortesse A, Thüroff J, Riis A, Nørgaard JP.
    Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
    [Abstract] [Full Text] [Related]

  • 12. The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury.
    Zahariou A, Karagiannis G, Papaioannou P, Stathi K, Michail X.
    Eura Medicophys; 2007 Sep; 43(3):333-8. PubMed ID: 17021585
    [Abstract] [Full Text] [Related]

  • 13. Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron.
    Zachariou A, Filiponi M, Baltogiannis D, Giannakis J, Dimitriadis F, Tsounapi P, Takenaka A, Sofikitis N.
    Can J Urol; 2017 Dec; 24(6):9107-9113. PubMed ID: 29260636
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
    Martín-Crespo R, Luque R.
    Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
    [Abstract] [Full Text] [Related]

  • 16. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P, Wormland RT, Möhring C, Goepel M.
    Neurourol Urodyn; 2009 Oct; 28(3):209-13. PubMed ID: 19205067
    [Abstract] [Full Text] [Related]

  • 17. The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect.
    Hvistendahl GM, Riis A, Nørgaard JP, Djurhuus JC.
    BJU Int; 2005 Apr; 95(6):804-9. PubMed ID: 15794787
    [Abstract] [Full Text] [Related]

  • 18. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria.
    Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T.
    Clin Auton Res; 2003 Apr; 13(2):106-8. PubMed ID: 12720096
    [Abstract] [Full Text] [Related]

  • 19. Gender differences in nighttime plasma arginine vasopressin and delayed compensatory urine output in the elderly population after desmopressin.
    Hvistendahl GM, Frøkiaer J, Nielsen S, Djurhuus JC.
    J Urol; 2007 Dec; 178(6):2671-6. PubMed ID: 17945283
    [Abstract] [Full Text] [Related]

  • 20. The evaluation of desmopressin in treatment of adolescent nocturnal enuresis.
    Derman O, Kanbur NO, Kinik E.
    Int J Adolesc Med Health; 2004 Dec; 16(4):377-85. PubMed ID: 15712975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.